45 related articles for article (PubMed ID: 15307923)
1. HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected Ugandans.
Rutebemberwa A; Auma B; Gilmour J; Jones G; Yirrell D; Rowland S; Imami N; Watera C; Kaleebu P; Whitworth J; Gotch F
AIDS Res Hum Retroviruses; 2004 Jul; 20(7):763-71. PubMed ID: 15307923
[TBL] [Abstract][Full Text] [Related]
2. An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa.
Eshofonie A; van der Loeff MS; Whittle H; Jaye A
Clin Exp Immunol; 2006 Dec; 146(3):471-8. PubMed ID: 17100767
[TBL] [Abstract][Full Text] [Related]
3. Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B- and F1- than in C-infected subjects.
Côrtes FH; Bello G; Vorsatz C; Pilotto JH; Guimarães ML; Grinsztejn B; Veloso VG; Pinto AR; Morgado MG
Vaccine; 2013 Feb; 31(7):1106-12. PubMed ID: 23261042
[TBL] [Abstract][Full Text] [Related]
4. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
[TBL] [Abstract][Full Text] [Related]
5. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of gag-specific IFN-gamma secretion responses in HIV-1 B/C recombinant infectors].
Liu HW; Hong KX; Yuan Y; Liu CH; Chen JP; Ruan YH; Wang Z; Shao YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):358-60. PubMed ID: 22338224
[TBL] [Abstract][Full Text] [Related]
7. A vaccinia-based elispot assay for detection of CD8+ T cells from HIV-1 infected children.
Buseyne F; Catteau A; Scott-Algara D; Corre B; Porrot F; Rouzioux C; Blanche S; Rivière Y
J Immunol Methods; 2005 Mar; 298(1-2):105-18. PubMed ID: 15847801
[TBL] [Abstract][Full Text] [Related]
8. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
[TBL] [Abstract][Full Text] [Related]
9. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of recombinant Modified Vaccinia Ankara Viruses (rMVA) expressing HIV-1 Indian subtype C gag-protease and env-gp120 genes in mice.
Kumar S; Seth P
Viral Immunol; 2004; 17(4):574-9. PubMed ID: 15671754
[TBL] [Abstract][Full Text] [Related]
11. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
Lukashov VV; Cornelissen MT; Goudsmit J; Papuashvilli MN; Rytik PG; Khaitov RM; Karamov EV; de Wolf F
AIDS; 1995 May; 9(5):435-9. PubMed ID: 7639968
[TBL] [Abstract][Full Text] [Related]
13. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
[TBL] [Abstract][Full Text] [Related]
14. In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype.
Geldmacher C; Currier JR; Gerhardt M; Haule A; Maboko L; Birx D; Gray C; Meyerhans A; Cox J; Hoelscher M
AIDS; 2007 Jan; 21(2):135-43. PubMed ID: 17197803
[TBL] [Abstract][Full Text] [Related]
15. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
16. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
Jansen CA; Kostense S; Vandenberghe K; Nanlohy NM; De Cuyper IM; Piriou E; Manting EH; Miedema F; van Baarle D
Eur J Immunol; 2005 Jan; 35(1):150-8. PubMed ID: 15593302
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents.
Coplan PM; Gupta SB; Dubey SA; Pitisuttithum P; Nikas A; Mbewe B; Vardas E; Schechter M; Kallas EG; Freed DC; Fu TM; Mast CT; Puthavathana P; Kublin J; Brown Collins K; Chisi J; Pendame R; Thaler SJ; Gray G; Mcintyre J; Straus WL; Condra JH; Mehrotra DV; Guess HA; Emini EA; Shiver JW
J Infect Dis; 2005 May; 191(9):1427-34. PubMed ID: 15809900
[TBL] [Abstract][Full Text] [Related]
18. HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians.
Ferrari G; Currier JR; Harris ME; Finkelstein S; de Oliveira A; Barkhan D; Cox JH; Zeira M; Weinhold KJ; Reinsmoen N; McCutchan F; Birx DL; Osmanov S; Maayan S
Hum Immunol; 2004 Jun; 65(6):648-59. PubMed ID: 15219385
[TBL] [Abstract][Full Text] [Related]
19. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally.
Makedonas G; Bruneau J; Alary M; Tsoukas CM; Lowndes CM; Lamothe F; Bernard NF
AIDS; 2005 Feb; 19(3):251-9. PubMed ID: 15718835
[TBL] [Abstract][Full Text] [Related]
20. Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles.
Gudmundsdotter L; Bernasconi D; Hejdeman B; Sandstrom E; Alaeus A; Lidman K; Ensoli B; Wahren B; Buttò S
Vaccine; 2008 Sep; 26(40):5182-7. PubMed ID: 18479789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
